S100A9 and colitis: Moreover, the anti-inflammatory effects of tasquinimod and hederacoside C were demonstrated by their ability to alleviate colitis, primarily through the inhibition of S100A9 release from MØ in mice [63] and neutrophils in a rat colitis model [64], respectively.